Endocrinology, Diabetes and MetabolismMedicine (miscellaneous)BiochemistryClinical BiochemistryEndocrinologyBiochemistry (medical)
Phân tích ảnh hưởng
Thông tin về tạp chí
The Journal of Clinical Endocrinology & Metabolism is the world"s leading peer-reviewed journal for endocrine clinical research and cutting edge clinical practice reviews. Each issue provides the latest in-depth coverage of new developments enhancing our understanding, diagnosis and treatment of endocrine and metabolic disorders. Regular features of special interest to endocrine consultants include clinical trials, clinical reviews, clinical practice guidelines, case seminars, and controversies in clinical endocrinology, as well as original reports of the most important advances in patient-oriented endocrine and metabolic research. According to the latest Thomson Reuters Journal Citation Report, JCE&M articles were cited 64,185 times in 2008.
Anthony P. Goldstone, Alexander D. Miras, Samantha Scholtz, Sabrina Jackson, K. Wolfgang Neff, Luc Pénicaud, Justin Geoghegan, Navpreet Chhina, Giuliana Durighel, Jimmy D. Bell, Sophie Meillon, Carel W. le Roux
Ana B. Crujeiras, Estíbaliz Goyenechea, Itziar Abete, Mary Lage, Marcos C. Carreira, J. Alfredo Martínéz, Felipe F. Casanueva
Context: Appetite-related hormones may play an important role in weight regain after obesity therapy.Objective: Our objective was to investigate the potential involvement of ghrelin, leptin, and insulin plasma levels in weight regain after a therapeutic hypocaloric diet.Design: A group of obese/overweight volunteers (49 women and 55 men; 35 ± 7 yr; 30.7 ± 2.4 kg/m2) followed an 8-wk hypocaloric diet (−30% energy expenditure) and were evaluated again 32 wk after treatment. Body weight as well as plasma fasting ghrelin, leptin, and insulin concentrations were measured at three points (wk 0, 8, and 32).Results: After the 8-wk hypocaloric diet, the average weight loss was −5.0 ± 2.2% (P < 0.001). Plasma leptin and insulin concentrations decreased significantly, whereas ghrelin levels did not markedly change. In the group regaining more than 10% of the weight loss, leptin levels were higher (P < 0.01), whereas ghrelin levels were lower (P < 0.05). No differences were observed in insulin levels. Weight regain at wk 32 was negatively correlated with ghrelin and positively associated with leptin levels at baseline (wk 0) and endpoint (wk 8). These outcomes showed a gender-specific influence, being statistically significant among men for ghrelin and between women for leptin. Moreover, a decrease in ghrelin after an 8-wk hypocaloric diet was related to an increased risk for weight regain (odds ratio = 3.109; P = 0.008) whereas a greater reduction in leptin (odds ratio = 0.141; P = 0.001) was related to weight-loss maintenance.Conclusions: Subjects with higher plasma leptin and lower ghrelin levels at baseline could be more prone to regain lost weight, and hormones levels could be proposed as biomarkers for predicting obesity-treatment outcomes.
AbstractContext:Changes in vascular permeability and expansion of the fluid-filled antrum are major events in the LH-induced ovulatory process.Objectives:Our objective was to investigate the presence and expression levels of aquaporins (AQPs) in the granulosa and theca cell compartments of the follicle during defined phases of human ovulation.Design and Setting:We conducted a prospective experimental study at the Department of Obstetrics and Gynaecology at a university hospital.Participants:Twenty-eight women underwent laparoscopic sterilization and at the same time follicle retrieval at four periovulatory phases.Main Outcome Measures:mRNA levels of AQP1-4 were measured in separated granulosa and theca cells from preovulatory phase, early ovulatory (EO) phase, late ovulatory phase, and postovulatory phase. Immunohistochemistry was done for AQP1-4 in intact human follicles.Results:All four AQPs were expressed in both the theca and granulosa cells during ovulation. In granulosa cells, AQP1 levels increased in the late ovulatory and postovulatory phases. Expression of AQP2-3 followed a similar pattern with a marked increase in the EO phase, whereas AQP4 levels decreased from preovulatory to the EO phase. The presence of AQP1-4 in the human follicle was verified by immunohistochemistry.Conclusions:The results show for the first time the presence of AQP1-4 in human follicles during ovulation. The marked early rise in expression of AQP2 and AQP3 suggests a role during the process leading to follicular rupture, and the late rise of AQP1 suggests a role in corpus luteum formation.
Jennifer L. Bolton, Émilie Montastier, Jérôme Carayol, Sophie Bonnel, Lucile Mir, Marie‐Adeline Marques, Arne Astrup, Wim H. M. Saris, Jason S. Iacovoni, Nathalie Villa‐Vialaneix, Armand Valsesia, Dominique Langin, Nathalie Viguerie
AbstractContextAlthough calorie restriction has proven beneficial for weight loss, long-term weight control is variable between individuals.ObjectiveTo identify biomarkers of successful weight control during a dietary intervention (DI).Design, Setting, and ParticipantsAdipose tissue (AT) transcriptomes were compared between 21 obese individuals who either maintained weight loss or regained weight during the DI. Results were validated on 310 individuals from the same study using quantitative reverse transcription polymerase chain reaction and protein levels of potential circulating biomarkers measured by enzyme-linked immunosorbent assay.InterventionIndividuals underwent 8 weeks of low-calorie diet, then 6 months of ad libitum diet.Outcome MeasureWeight changes at the end of the DI.ResultsWe evaluated six genes that had altered expression during DI, encode secreted proteins, and have not previously been implicated in weight control (EGFL6, FSTL3, CRYAB, TNMD, SPARC, IGFBP3), as well as genes for which baseline expression differed between those with good and poor weight control (ASPN, USP53). Changes in plasma concentrations of EGFL6, FSTL3, and CRYAB mirrored AT messenger RNA expression; all decreased during DI in individuals with good weight control. ASPN and USP53 had higher baseline expression in individuals who went on to have good weight control. Expression quantitative trait loci analysis found polymorphisms associated with expression levels of USP53 in AT. A regulatory network was identified in which transforming growth factor β1 (TGF-β1) was responsible for downregulation of certain genes during DI in good controllers. Interestingly, ASPN is a TGF-β1 inhibitor.ConclusionsWe found circulating biomarkers associated with weight control that could influence weight management strategies and genes that may be prognostic for successful weight control.